Form 4: Boston Scientific Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, reports the vesting of restricted stock units and subsequent disposal of shares to cover tax obligations.

Summary

  • On February 12, 2025, Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, reported transactions involving Boston Scientific common stock.
  • 480 restricted stock units vested, each representing the right to receive one share of Boston Scientific common stock.
  • Ms. Woodworth disposed of 231 shares of common stock at a price of $105.77 to satisfy tax obligations related to the vesting of the restricted stock units.
  • Following these transactions, Ms. Woodworth directly owns 3,206 shares of Boston Scientific common stock and 1,443 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.

Future Outlook

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Boston Scientific.

Comparison to Industry Standards

  • Form 4 filings are standard practice across all publicly traded companies in the US, ensuring transparency in insider trading.
  • Similar filings can be observed for executives at comparable medical device companies like Medtronic (MDT) and Abbott Laboratories (ABT).

Stakeholder Impact

  • The transactions have a minimal impact on shareholders, as they represent a small portion of the company's outstanding shares.
  • The filing provides transparency to stakeholders regarding executive compensation and stock ownership.

Key Dates

DateDescription
02/12/2025Date of earliest transaction: vesting of restricted stock units and disposal of shares.
02/12/2025Restricted stock units vest in four equal annual installments beginning on this date.
02/12/2028Expiration date of the restricted stock units.
02/14/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.